PCMA Calls on DOL to Protect Competition in the PBM Market, Rescind Duplicative Proposed Rule 

Today, the Pharmaceutical Care Management Association (PCMA) submitted formal comments to the Department of Labor (DOL) as part of the rulemaking process for the proposed regulation, “Improving Transparency into Pharmacy Benefit Manager Fee Disclosure.”   PCMA called on DOL to rescind the proposed rule because it is unnecessary and risks degrading a competitive and effective PBM industry. Specifically:   The proposal is blatantly redundant of the recently passed PBM reform legislation signed into law by President Trump,   The proposal offers nearly no additional meaningful transparency for employers, and The proposal threatens to reduce competition in the PBM market.     On releasing PCMA’s comment letter, David Marin, President […]